2015 CARE: MOC Session 2 - Nonrheumatic and Systemic Diseases and Crystal-Induced Arthropathies



Start Date:


End Date:




Max Credits:


Credit Type:




Program Information

Assess your rheumatology medical knowledge and enhance your patient care. This program combines 12 question pre and post-assessments with participation in a live session at the 2015 Annual Meeting or in the review of the posted session slides/materials.


Additional Program Information

With CARE: MOC Sessions 2015 – Session 2 - Nonrheumatic and Systemic Diseases and Crystal-Induced Arthropathies you receive:

  • Pre and post assessment consisting of 12 case-based, multiple-choice questions with in-depth answer rationales
  • Access to educational materials prepared by the session speakers
  • 4 AMA PRA Category 1 Credits™ and 4 ABIM MOC points with a passing score of 70% or higher


2015 Annual Meeting Live Session Information

Date: Monday, November 9, 12:30-2:00 pm  

Location: Moscone Center South – Esplanade, 304

Moderator: Carol A. Langford, MD, MHS

Speaker: Simon M. Helfgott, MD and Hyon K. Choi, MD, DrPH

Dr. Simon Helfgott is Associate Professor of Medicine at Harvard Medical School and Director of Education and Fellowship Training in the Division of Rheumatology at the Brigham and Women's Hospital. He is currently the physician editor of The Rheumatologist.

Dr. Hyon K. Choi is a Professor of Medicine at Harvard Medical School and the Director of the Gout and Crystal Arthropathy Center at Massachusetts General Hospital (MGH).  He also serves as the co-director of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).  Dr. Choi received his rheumatology training at Massachusetts General Hospital and Harvard Medical School, and his master’s and doctorate degrees from Harvard University. He has been a leading clinical rheumatologist-investigator with a primary focus on crystal arthropathy throughout his academic career, as reflected by his NIH funding, over 200 publications (including original articles published in NEJM, JAMA, Lancet, Nature, Ann Int Med, BMJ, Arch Int Med, Ann Rheum Dis, A&R, and others), and reviewer activities for top journals and the NIH.  Dr. Choi’s findings have been referenced by many key articles and the recent guidelines from the ACR and EULAR.


Each stage must be completed in sequential order:

Stage A. Complete the 12 question pre-assessment

Stage B.  Attest you will complete the educational intervention

Intervention options are:

  • Attending the live session on Monday, November 9 from 12:30-2:00 pm in Moscone Center South – Esplanade, 304


  • Reviewing the session materials posted in this module

Stage C. Complete the 12 question post-assessment with a minimum score of 70%

  • Compare your Stage A and Stage C results
  • Submit Activity Evaluation for CME
  • ACR will submit your results to the ABIM for your MOC points to reflect on your ABIM MOC Profile

Registration Fees

  • Members/Nonmembers - $30

CME and MOC Information


Accreditation Statement

The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement

The ACR designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities. 

MOC Statement

Successful completion of this CME activity enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Claim MOC Points

  • Select the MOC checkbox to claim MOC points equal to the number of CME hours claimed.
  • MOC points are submitted to ABIM each day at 11:30 PM EST. After points are submitted, ABIM will not accept changes.
  • If you are submitting MOC points, check your ABIM Physician Portal 24 - 48 hours after submission to make sure your MOC points are reflected.

Learning Objectives

Upon completion of this activity, learners should be able to:

  1. Determine the appropriate testing and evaluation of results to confirm suspicions of disease
  2. Evaluate clinical clues (comorbidities, indications related to ethnic background, disease mimicry) in distinguishing between possible diagnoses
  3. Identify ideal treatment approaches based on combination of patient education, lifestyle and appropriate use of available therapies.

Release Date: November 2, 2015

Expiration Date: November 1, 2018


Use of Professional Judgment

The CARE Program, including all educational links is intended to be used as a tool to assess the rheumatology base medical knowledge of the learner. The information presented relates to basic principles of diagnosis and therapy, and is meant in no way to substitute for an individual patient assessment based upon the healthcare provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient.

Drugs and Doses

When prescribing medications, the health professional is advised to check the prescribing information accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications. 

ACR Disclosure Statement

The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. The CARE: MOC Sessions 2015 Program has been independently planned by the Self-Assessment Program Development Group under the Continuous Professional Development Committee, and the ACR Committee on Education.

CARE: MOC Sessions 2015 Development Faculty Disclosures

View ACR's ACCME disclosure practices >

Faculty participating in an ACR-sponsored activity must disclose to the planning committee and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures: 

Moderator: Carol A. Langford, MD, MHS – None
Speaker: Simon M. Helfgott, MD – None
Speaker: Hyon K. Choi, MD, DrPH – None
Question Author: William Ayoub, MD – Bristol Myers Squibb8